P3 Prostate Cancer Forum: 2024

Session 1 - Prostate Cancer Screening: Current Perspectives on effective management

In session 1, explore valuable insights on prostate cancer screening. Our expert panel delve into the changing dynamics within screening in the UK and the EU, including the latest on the TRANSFORM study.

The session is been split into three sections:

Prostate Cancer Screening: Prostate Cancer UK’s Position, plans and priorities - Dr Matthew Hobbs

Prostate Cancer Screening – a European Model – Prof Phil Cornford

Prostate Cancer Screening in the UK – are we ready for a change? – Professor Caroline Moore

Prostate Cancer Screening: Prostate Cancer UK’s Position, plans and priorities

Dr Matthew Hobbs

NUBEQA (darolutamide) Prescribing Information

Xofigo

^▼ (radium-223 dichloride) Prescribing Information

Meeting Summary Downloadable

Download the summary below for the key takeaways from this meeting.

View here

Speakers

Professor Caroline Moore
Professor Caroline Moore
Professor of Urology at University College London in the Department of Targeted Intervention
Professor Philip Cornford
Professor Philip Cornford
Honorary Associate Professor, Liverpool University Hospitals NHS Foundation Trust, Chair of EAU Prostate Cancer Guidelines Panel
Dr Matthew Hobbs
Dr Matthew Hobbs
Director of Research, Prostate Cancer UK

Session 2 - Decoding mHSPC: Unravelling the complexities

In session 2, our experts share their insights on optimising treatment in mHSPC, delving specifically into triple therapy: data, case studies and holistic patient management.

Watch here

PP-NUB-GB-1919, October 2024

Session 2: Decoding mHSPC: Unravelling the complexities

Our experts share their insights on optimising treatment in mHSPC, delving specifically into triple therapy.

PP-NUB-GB-2016, January 2025

PP-NUB-GB-2013 | January 2025